NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

AAVAS Financiers Research Report

Key Highlights

  • AAVAS Financiers has navigated management changes, promoter stake sale, and regulatory headwinds over the past three years, which are now largely subsided.
  • Disbursements are expected to increase driven by branch expansion, CSC scale-up, and the RRO model.
  • The company projects AUM growth of 18% in FY27 and 20% in FY28E.

Outlook and Recommendations

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

We expect AAVAS Financiers to maintain its growth trajectory driven by branch expansion and the RRO model. However, execution in non-RJ markets is crucial for achieving projected growth rates. A potential credit rating upgrade by July-26 is likely to support net interest margins (NIMs).

Financial Projections

  • Expected AUM growth: 18% in FY27 and 20% in FY28E
  • Net interest margins (NIMs) expected to benefit from a potential credit rating upgrade
  • Operating expenses (Opex) are expected to be elevated in FY27 due to new branch additions
  • Credit cost is expected to remain benign at 15-16bps

Investment Recommendation

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

We maintain a BUY rating on AAVAS Financiers with a target price of Rs 1,500 (1.8x FY28E P/ABV). The stock has corrected 11.5% over the past month, providing an attractive entry point for investors.

Investor Takeaway

Investors should maintain a BUY on AAVAS Financiers due to its sustainable growth and margin outlook.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.